Interleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset-Reference-Cited by-同舟云学术

Interleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset

Published:2016-01-21 Issue:4 Volume:46 Page:1030-1046
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Cabrera Susanne M.¹,Wang Xujing²,Chen Yi-Guang¹,Jia Shuang¹,Kaldunski Mary L.¹,Greenbaum Carla J.³,Mandrup-Poulsen Thomas⁴⁵,Hessner Martin J.¹, ,

Affiliation:

1. The Max McGee National Research Center for Juvenile Diabetes; Children's Research Institute of Children's Hospital of Wisconsin; and Department of Pediatrics at the Medical College of Wisconsin; Milwaukee WI USA

2. Systems Biology Center; the National Heart; Lung; and Blood Institute, the National Institutes of Health; Bethesda MD USA

3. Diabetes Research Program; Benaroya Research Institute; Seattle WA USA

4. Department of Biomedical Sciences; Faculty of Health and Medical Sciences; University of Copenhagen; Copenhagen Denmark

5. Department of Molecular Medicine and Surgery; Karolinska Institutet; Stockholm Sweden

Funder

Juvenile Diabetes Research Foundation International

American Diabetes Association

National Institutes of Health

National Center for Advancing Translational Sciences, National Institutes of Health

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference38 articles.

1. Blockade of interleukin 1 in type 1 diabetes mellitus;Mandrup-Poulsen;Nat. Rev. Endocrinol.,2010

2. Etiology of type 1 diabetes;Todd;Immunity,2010

3. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset;Stiller;Science,1984

4. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes;Keymeulen;N. Engl. J. Med.,2005

5. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function;Pescovitz;N. Engl. J. Med.,2009

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoimmune diseases: targets, biology, and drug discovery;Acta Pharmacologica Sinica;2023-12-14

2. A standardized metric to enhance clinical trial design and outcome interpretation in type 1 diabetes;Nature Communications;2023-11-08

3. Inflammation versus regulation: how interferon-gamma contributes to type 1 diabetes pathogenesis;Frontiers in Cell and Developmental Biology;2023-05-24

4. Preclinical models for Type 1 Diabetes Mellitus - A practical approach for research;International Journal of Medical Sciences;2023

5. Rethinking Clinical Trial Outcomes: Use of a Standardized Metric to Enhance Design and Interpretation;2022-12-22